HEADLINE STOCKS-U.S. small/midcap stocks to watch on Nov 2 - News

Runway Angels
The superbowl of fashion shows, models walk down the runway at the 2009 Victoria's Secret Fashion Show.
The Richest Members of the US Congress
Recently, the Center for Responsive Politics found that there are 237 millionaires in the US Congress.
10 Tips to Get Out of Debt
Renowned financial author Gail Vaz-Oxlade takes a tough-love approach to helping couples in a financial crisis to face reality.

FEATURED QUIZZES

How Much Do You Know About Green?
Green has become part of our everyday lives. Green is everywhere-- energy, clothing, food, housing, transportation. It's a big business and a global business.
The Billionaire BFF's
Philanthropists. Bridge partners. Hockey players. Which responses are based on facts from Buffett's and Gates' real lives?
The Many Myths of Coca-Cola
Can you tell which statements are true, and which ones are just rumors?

SPECIAL REPORTS

Winterizing Your Portfolio
If 2009 was the winter of our discontent, will 2010 be a winter wonderland for investors? A lot depends on the recovery—or lack thereof.
Investor's Guide to Real Estate
Some even say the long-awaited recovery is here. Regardless, buyers and sellers alike can profit from our guide.
Alternative Investing
Stocks and bonds? Sure. But it's a big world out there for investors.

CNBC ON DIGG

HEADLINE STOCKS-U.S. small/midcap stocks to watch on Nov 2

By: AFX | 02 Nov 2009 | 02:26 PM ET

Text Size

(Updates share prices, adds Revlon, CapitalSource) (For large-cap stocks to watch, click on) Nov 2 (Reuters) - Some small and midcap stocks to watch on Monday: REVLON INC, $9.31, up 10 percent The cosmetics maker said one of its units was seeking to amend its bank term-loan and bank revolver credit agreements. CAPITALSOURCE INC, $3.22, down 10 percent The commercial lender posted a third-quarter loss of $274 million, hurt mainly by a two-fold rise in bad loan provisions and an accounting charge. RBC BEARINGS INC, $20.74, down 4 percent The ball bearings maker posted second-quarter results below market expectations. GTX INC, $4.75, down 47 percent The company said the U.S. health regulators did not approve its experimental drug to reduce fractures in men with prostate cancer citing clinical deficiencies and asked the company to conduct a second late-stage study, sending GTx shares down. PERRIGO CO, $38.23, up 3 percent The generic drug maker posted better-than-expected quarterly results and guided full-year earnings above Street projections. TESSERA TECHNOLOGIES INC, $21.27, down 4 percent The U.S. International Trade Commission will review whether certain DRAM manufacturers and sellers infringed Tessera's patents, the chip technology developer said. (Reporting by Supantha Mukherjee in Bangalore) Keywords: MARKETS STOCKS SMALLCAP (supantha.mukherjee@thomsonreuters.com; within U.S.+1 646 223 8780; outside U.S.

The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

Tools: